FDA OKs New Keytruda Shot for Cancer

[ad_1]

Merck says an injected version of its blockbuster infusion Keytruda is quicker and easier. But it stands to slow the adoption of cheaper competitors, increasing costs by billions of dollars.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *